Novel pathogenic mutations and skin biopsy analysis in Knobloch syndrome


Autoria(s): SUZUKI, Oscar; KAGUE, Erika; BAGATINI, Kelly; TU, Hongmin; HELJASVAARA, Ritva; CARVALHAES, Lorenza; GAVA, Elisandra; OLIVEIRA, Gisele de; GODOI, Paulo; OLIVA, Glaucius; KITTEN, Gregory; PIHLAJANIEMI, Taina; PASSOS-BUENO, Maria-Rita
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/04/2012

19/04/2012

2009

Resumo

Purpose: To facilitate future diagnosis of Knobloch syndrome (KS) and better understand its etiology, we sought to identify not yet described COL18A1 mutations in KS patients. In addition, we tested whether mutations in this gene lead to absence of the COL18A1 gene product and attempted to better characterize the functional effect of a previously reported missense mutation. Methods: Direct sequencing of COL18A1 exons was performed in KS patients from four unrelated pedigrees. We used immunofluorescent histochemistry in skin biopsies to evaluate the presence of type XVIII collagen in four KS patients carrying two already described mutations: c. 3277C>T, a nonsense mutation, and c. 3601G>A, a missense mutation. Furthermore, we determined the binding properties of the mutated endostatin domain p.A1381T (c.3601G>A) to extracellular matrix proteins using ELISA and surface plasmon resonance assays. Results: We identified four novel mutations in COL18A1, including a large deletion involving exon 41. Skin biopsies from KS patients revealed lack of type XVIII collagen in epithelial basement membranes and blood vessels. We also found a reduced affinity of p.A1381T endostatin to some extracellular matrix components. Conclusions: COL18A1 mutations involved in Knobloch syndrome have a distribution bias toward the coding exons of the C-terminal end. Large deletions must also be considered when point mutations are not identified in patients with characteristic KS phenotype. We report, for the first time, lack of type XVIII collagen in KS patients by immunofluorescent histochemistry in skin biopsy samples. As a final point, we suggest the employment of this technique as a preliminary and complementary test for diagnosis of KS in cases when mutation screening either does not detect mutations or reveals mutations of uncertain effect, such as the p.A1381T change.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) - CEPID

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Identificador

MOLECULAR VISION, v.15, n.82, p.801-809, 2009

1090-0535

http://producao.usp.br/handle/BDPI/16587

http://www.molvis.org/molvis/v15/a82/mv-v15-a82-suzuki.pdf

Idioma(s)

eng

Publicador

MOLECULAR VISION

Relação

Molecular Vision

Direitos

openAccess

Copyright MOLECULAR VISION

Palavras-Chave #ANGIOGENESIS INHIBITOR ENDOSTATIN #COLLAGEN-XVIII #TUMOR-GROWTH #GENETIC-HETEROGENEITY #ENDOGENOUS INHIBITOR #MOLECULAR ANALYSIS #BINDING #COL18A1 #FORMS #DEGENERATION #Biochemistry & Molecular Biology #Ophthalmology
Tipo

article

original article

publishedVersion